Creech, Clarence Buddy
- Vanderbilt University Medical Center (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #2,339
- Rising Star
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2008 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$2.6M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#2,339
By linked amount among FY2023 PIs
Earliest Year Loaded
2008
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Creech, Clarence Buddy as a PI. Multi-PI records show the full award amount for context.
- 3UM1AI148452-04S1UM1Contact PIVanderbilt Vaccine and Treatment Evaluation Unit$2Maward amount
- 5UM1AI148452-04UM1Contact PIVanderbilt Vaccine and Treatment Evaluation Unit$650.7Kaward amount
Award organization
Organizations that administered FY2023 awards listing Creech, Clarence Buddy as a PI.
FY2023 award administered by Vanderbilt University Medical Center (TN).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2008First NIH AwardVanderbilt University Medical Center
- 2015$500K Cumulative Funding
- 2015$1M Cumulative Funding
- 2016$2M Cumulative Funding
- 2016Entered Top 50% NationallyRanked #4212
- 2016Entered Top 25% NationallyRanked #4212
- 2017$5M Cumulative Funding
- 2017Entered Top 10% NationallyRanked #600
- 2017Entered Top 5% NationallyRanked #600
- 2018$10M Cumulative Funding
- 2021$25M Cumulative Funding
- 2021Entered Top 1% NationallyRanked #148